nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—HIF1A—gall bladder—celiac disease	0.0211	0.0371	CbGeAlD
Carvedilol—NPPB—smooth muscle tissue—celiac disease	0.0176	0.0309	CbGeAlD
Carvedilol—NPPB—pancreas—celiac disease	0.0162	0.0286	CbGeAlD
Carvedilol—NPPB—lymphoid tissue—celiac disease	0.014	0.0247	CbGeAlD
Carvedilol—NPPB—blood—celiac disease	0.0132	0.0233	CbGeAlD
Carvedilol—SELE—connective tissue—celiac disease	0.013	0.0229	CbGeAlD
Carvedilol—SELE—epithelium—celiac disease	0.0123	0.0217	CbGeAlD
Carvedilol—VCAM1—connective tissue—celiac disease	0.0119	0.021	CbGeAlD
Carvedilol—SELE—smooth muscle tissue—celiac disease	0.0119	0.0209	CbGeAlD
Carvedilol—HIF1A—connective tissue—celiac disease	0.0115	0.0202	CbGeAlD
Carvedilol—VCAM1—epithelium—celiac disease	0.0113	0.02	CbGeAlD
Carvedilol—GJA1—connective tissue—celiac disease	0.0111	0.0196	CbGeAlD
Carvedilol—VCAM1—smooth muscle tissue—celiac disease	0.0109	0.0192	CbGeAlD
Carvedilol—HIF1A—epithelium—celiac disease	0.0109	0.0192	CbGeAlD
Carvedilol—GJA1—epithelium—celiac disease	0.0106	0.0186	CbGeAlD
Carvedilol—HIF1A—smooth muscle tissue—celiac disease	0.0105	0.0185	CbGeAlD
Carvedilol—ADRB3—connective tissue—celiac disease	0.0102	0.018	CbGeAlD
Carvedilol—GJA1—smooth muscle tissue—celiac disease	0.0102	0.0179	CbGeAlD
Carvedilol—VCAM1—pancreas—celiac disease	0.0101	0.0178	CbGeAlD
Carvedilol—CYP1A2—urine—celiac disease	0.00982	0.0173	CbGeAlD
Carvedilol—HIF1A—pancreas—celiac disease	0.00971	0.0171	CbGeAlD
Carvedilol—SELE—lymphoid tissue—celiac disease	0.00949	0.0167	CbGeAlD
Carvedilol—GJA1—pancreas—celiac disease	0.00942	0.0166	CbGeAlD
Carvedilol—SELE—digestive system—celiac disease	0.00937	0.0165	CbGeAlD
Carvedilol—CYP2C9—urine—celiac disease	0.00932	0.0164	CbGeAlD
Carvedilol—NDUFC2—epithelium—celiac disease	0.00921	0.0162	CbGeAlD
Carvedilol—SELE—blood—celiac disease	0.00893	0.0157	CbGeAlD
Carvedilol—CYP2E1—urine—celiac disease	0.00884	0.0156	CbGeAlD
Carvedilol—VCAM1—lymphoid tissue—celiac disease	0.00873	0.0154	CbGeAlD
Carvedilol—VCAM1—digestive system—celiac disease	0.00862	0.0152	CbGeAlD
Carvedilol—HIF1A—lymphoid tissue—celiac disease	0.0084	0.0148	CbGeAlD
Carvedilol—HIF1A—digestive system—celiac disease	0.00829	0.0146	CbGeAlD
Carvedilol—VCAM1—blood—celiac disease	0.00821	0.0145	CbGeAlD
Carvedilol—GJA1—lymphoid tissue—celiac disease	0.00815	0.0143	CbGeAlD
Carvedilol—VEGFA—smooth muscle tissue—celiac disease	0.00805	0.0142	CbGeAlD
Carvedilol—GJA1—digestive system—celiac disease	0.00805	0.0142	CbGeAlD
Carvedilol—HIF1A—blood—celiac disease	0.0079	0.0139	CbGeAlD
Carvedilol—VEGFA—pancreas—celiac disease	0.00744	0.0131	CbGeAlD
Carvedilol—CYP3A4—urine—celiac disease	0.00711	0.0125	CbGeAlD
Carvedilol—NDUFC2—lymphoid tissue—celiac disease	0.00709	0.0125	CbGeAlD
Carvedilol—NDUFC2—digestive system—celiac disease	0.007	0.0123	CbGeAlD
Carvedilol—CYP2D6—urine—celiac disease	0.007	0.0123	CbGeAlD
Carvedilol—SELE—liver—celiac disease	0.00698	0.0123	CbGeAlD
Carvedilol—NDUFC2—blood—celiac disease	0.00667	0.0117	CbGeAlD
Carvedilol—VCAM1—liver—celiac disease	0.00642	0.0113	CbGeAlD
Carvedilol—HIF1A—liver—celiac disease	0.00618	0.0109	CbGeAlD
Carvedilol—GJA1—liver—celiac disease	0.00599	0.0106	CbGeAlD
Carvedilol—XDH—digestive system—celiac disease	0.00566	0.00996	CbGeAlD
Carvedilol—ADRA1D—epithelium—celiac disease	0.00546	0.00961	CbGeAlD
Carvedilol—NDUFC2—liver—celiac disease	0.00522	0.00919	CbGeAlD
Carvedilol—VEGFA—liver—celiac disease	0.00473	0.00834	CbGeAlD
Carvedilol—XDH—liver—celiac disease	0.00421	0.00742	CbGeAlD
Carvedilol—ADRB1—connective tissue—celiac disease	0.00417	0.00735	CbGeAlD
Carvedilol—ADRA1A—epithelium—celiac disease	0.00313	0.00552	CbGeAlD
Carvedilol—ADRA2C—pancreas—celiac disease	0.00266	0.00468	CbGeAlD
Carvedilol—CYP1A1—epithelium—celiac disease	0.00256	0.0045	CbGeAlD
Carvedilol—ADRA2A—connective tissue—celiac disease	0.00251	0.00442	CbGeAlD
Carvedilol—ADRA1A—lymphoid tissue—celiac disease	0.00241	0.00425	CbGeAlD
Carvedilol—PTGS1—connective tissue—celiac disease	0.00237	0.00417	CbGeAlD
Carvedilol—ADRA1A—blood—celiac disease	0.00227	0.004	CbGeAlD
Carvedilol—PTGS1—epithelium—celiac disease	0.00225	0.00395	CbGeAlD
Carvedilol—KCNH2—blood—celiac disease	0.00219	0.00386	CbGeAlD
Carvedilol—ADRA2C—blood—celiac disease	0.00216	0.00381	CbGeAlD
Carvedilol—PTGS1—smooth muscle tissue—celiac disease	0.00216	0.00381	CbGeAlD
Carvedilol—ADRA2A—pancreas—celiac disease	0.00212	0.00374	CbGeAlD
Carvedilol—CYP1A2—digestive system—celiac disease	0.00197	0.00347	CbGeAlD
Carvedilol—CYP1A1—digestive system—celiac disease	0.00194	0.00342	CbGeAlD
Carvedilol—CYP1A2—blood—celiac disease	0.00188	0.00331	CbGeAlD
Carvedilol—CYP2C9—digestive system—celiac disease	0.00187	0.0033	CbGeAlD
Carvedilol—CYP1A1—blood—celiac disease	0.00185	0.00326	CbGeAlD
Carvedilol—CYP2E1—lymphoid tissue—celiac disease	0.0018	0.00316	CbGeAlD
Carvedilol—CYP2C9—blood—celiac disease	0.00178	0.00314	CbGeAlD
Carvedilol—ADRA1A—liver—celiac disease	0.00178	0.00313	CbGeAlD
Carvedilol—CYP2E1—digestive system—celiac disease	0.00177	0.00312	CbGeAlD
Carvedilol—ADRA2A—blood—celiac disease	0.00173	0.00304	CbGeAlD
Carvedilol—PTGS1—digestive system—celiac disease	0.00171	0.00301	CbGeAlD
Carvedilol—ADRA2C—liver—celiac disease	0.00169	0.00298	CbGeAlD
Carvedilol—CYP2E1—blood—celiac disease	0.00169	0.00297	CbGeAlD
Carvedilol—PTGS1—blood—celiac disease	0.00163	0.00287	CbGeAlD
Carvedilol—CYP1A2—liver—celiac disease	0.00147	0.00259	CbGeAlD
Carvedilol—CYP1A1—liver—celiac disease	0.00145	0.00255	CbGeAlD
Carvedilol—CYP3A4—digestive system—celiac disease	0.00143	0.00251	CbGeAlD
Carvedilol—CYP2D6—digestive system—celiac disease	0.0014	0.00247	CbGeAlD
Carvedilol—CYP2C9—liver—celiac disease	0.00139	0.00245	CbGeAlD
Carvedilol—CYP3A4—blood—celiac disease	0.00136	0.00239	CbGeAlD
Carvedilol—CYP2D6—blood—celiac disease	0.00134	0.00236	CbGeAlD
Carvedilol—ABCB1—epithelium—celiac disease	0.00133	0.00234	CbGeAlD
Carvedilol—CYP2E1—liver—celiac disease	0.00132	0.00233	CbGeAlD
Carvedilol—ABCB1—pancreas—celiac disease	0.00118	0.00208	CbGeAlD
Carvedilol—CYP3A4—liver—celiac disease	0.00106	0.00187	CbGeAlD
Carvedilol—CYP2D6—liver—celiac disease	0.00105	0.00184	CbGeAlD
Carvedilol—ABCB1—lymphoid tissue—celiac disease	0.00102	0.0018	CbGeAlD
Carvedilol—ABCB1—digestive system—celiac disease	0.00101	0.00178	CbGeAlD
Carvedilol—ABCB1—blood—celiac disease	0.000962	0.00169	CbGeAlD
Carvedilol—VEGFA—Hemostasis—PLEK—celiac disease	0.000882	0.00204	CbGpPWpGaD
Carvedilol—VCAM1—Adaptive Immune System—HLA-DQA1—celiac disease	0.000881	0.00204	CbGpPWpGaD
Carvedilol—ADRA2C—G alpha (i) signalling events—RGS1—celiac disease	0.000879	0.00203	CbGpPWpGaD
Carvedilol—ABCB1—HIF-1-alpha transcription factor network—ETS1—celiac disease	0.000873	0.00202	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—MBL2—celiac disease	0.000845	0.00196	CbGpPWpGaD
Carvedilol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.000836	0.00194	CbGpPWpGaD
Carvedilol—VCAM1—Adaptive Immune System—HLA-DQB1—celiac disease	0.000824	0.00191	CbGpPWpGaD
Carvedilol—KCNH2—SIDS Susceptibility Pathways—IL10—celiac disease	0.0008	0.00185	CbGpPWpGaD
Carvedilol—XDH—Metabolism—LCT—celiac disease	0.000799	0.00185	CbGpPWpGaD
Carvedilol—VCAM1—Adaptive Immune System—CD8A—celiac disease	0.00077	0.00178	CbGpPWpGaD
Carvedilol—ADRA2A—Platelet activation, signaling and aggregation—PLEK—celiac disease	0.000765	0.00177	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—FCGR2A—celiac disease	0.000764	0.00177	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—ARHGAP31—celiac disease	0.000753	0.00174	CbGpPWpGaD
Carvedilol—ABCB1—liver—celiac disease	0.000752	0.00133	CbGeAlD
Carvedilol—VEGFA—Signaling Pathways—ARHGAP31—celiac disease	0.000751	0.00174	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—TNFAIP3—celiac disease	0.00075	0.00174	CbGpPWpGaD
Carvedilol—ADRB3—GPCR ligand binding—CCR4—celiac disease	0.000749	0.00173	CbGpPWpGaD
Carvedilol—ADRA1D—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.000748	0.00173	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—PTPN2—celiac disease	0.000733	0.0017	CbGpPWpGaD
Carvedilol—ADRA2B—G alpha (i) signalling events—CCR4—celiac disease	0.000727	0.00168	CbGpPWpGaD
Carvedilol—ADRA2A—G alpha (i) signalling events—RGS1—celiac disease	0.000714	0.00165	CbGpPWpGaD
Carvedilol—ABCB1—Allograft Rejection—IL17A—celiac disease	0.000692	0.0016	CbGpPWpGaD
Carvedilol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.000681	0.00158	CbGpPWpGaD
Carvedilol—ADRA2C—G alpha (i) signalling events—CCR4—celiac disease	0.00068	0.00157	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—RGS1—celiac disease	0.000679	0.00157	CbGpPWpGaD
Carvedilol—ADRA2B—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.000675	0.00156	CbGpPWpGaD
Carvedilol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.000666	0.00154	CbGpPWpGaD
Carvedilol—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.000641	0.00148	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—HLA-DPB1—celiac disease	0.00064	0.00148	CbGpPWpGaD
Carvedilol—ABCB1—Allograft Rejection—HLA-DPB1—celiac disease	0.000638	0.00148	CbGpPWpGaD
Carvedilol—ADRB3—GPCR ligand binding—CCR3—celiac disease	0.000637	0.00147	CbGpPWpGaD
Carvedilol—ADRA1D—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.000636	0.00147	CbGpPWpGaD
Carvedilol—ADRA2C—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.000631	0.00146	CbGpPWpGaD
Carvedilol—VCAM1—Adaptive Immune System—HLA-DRB1—celiac disease	0.000627	0.00145	CbGpPWpGaD
Carvedilol—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.000621	0.00144	CbGpPWpGaD
Carvedilol—ADRA2B—G alpha (i) signalling events—CCR3—celiac disease	0.000619	0.00143	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—CTLA4—celiac disease	0.000607	0.0014	CbGpPWpGaD
Carvedilol—ABCB1—Allograft Rejection—CTLA4—celiac disease	0.000605	0.0014	CbGpPWpGaD
Carvedilol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.000584	0.00135	CbGpPWpGaD
Carvedilol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.000579	0.00134	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—CD79A—celiac disease	0.000579	0.00134	CbGpPWpGaD
Carvedilol—VCAM1—Adaptive Immune System—CD80—celiac disease	0.000579	0.00134	CbGpPWpGaD
Carvedilol—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.000578	0.00134	CbGpPWpGaD
Carvedilol—ADRA2C—G alpha (i) signalling events—CCR3—celiac disease	0.000578	0.00134	CbGpPWpGaD
Carvedilol—ADRA2B—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.000574	0.00133	CbGpPWpGaD
Carvedilol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.000571	0.00132	CbGpPWpGaD
Carvedilol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.000567	0.00131	CbGpPWpGaD
Carvedilol—VEGFA—Hemostasis—SH2B3—celiac disease	0.000554	0.00128	CbGpPWpGaD
Carvedilol—ADRA2A—G alpha (i) signalling events—CCR4—celiac disease	0.000552	0.00128	CbGpPWpGaD
Carvedilol—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.000551	0.00128	CbGpPWpGaD
Carvedilol—ADRB3—GPCR downstream signaling—RGS1—celiac disease	0.000548	0.00127	CbGpPWpGaD
Carvedilol—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.000545	0.00126	CbGpPWpGaD
Carvedilol—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.00054	0.00125	CbGpPWpGaD
Carvedilol—ADRA2C—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.000536	0.00124	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—HLA-DQA1—celiac disease	0.000534	0.00124	CbGpPWpGaD
Carvedilol—ABCB1—Allograft Rejection—HLA-DQA1—celiac disease	0.000532	0.00123	CbGpPWpGaD
Carvedilol—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.000532	0.00123	CbGpPWpGaD
Carvedilol—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.000528	0.00122	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—CCR4—celiac disease	0.000525	0.00121	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—PLEK—celiac disease	0.00052	0.0012	CbGpPWpGaD
Carvedilol—ADRA2A—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.000512	0.00119	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—HLA-DQB1—celiac disease	0.0005	0.00116	CbGpPWpGaD
Carvedilol—ABCB1—Allograft Rejection—HLA-DQB1—celiac disease	0.000498	0.00115	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—RGS1—celiac disease	0.000497	0.00115	CbGpPWpGaD
Carvedilol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.000496	0.00115	CbGpPWpGaD
Carvedilol—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.000492	0.00114	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—ARHGAP31—celiac disease	0.00049	0.00113	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR ligand binding—CCR4—celiac disease	0.000488	0.00113	CbGpPWpGaD
Carvedilol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.000486	0.00112	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—PLEK—celiac disease	0.000485	0.00112	CbGpPWpGaD
Carvedilol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.000472	0.00109	CbGpPWpGaD
Carvedilol—ABCB1—Allograft Rejection—IL10—celiac disease	0.00047	0.00109	CbGpPWpGaD
Carvedilol—ADRA2A—G alpha (i) signalling events—CCR3—celiac disease	0.000469	0.00109	CbGpPWpGaD
Carvedilol—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.000469	0.00108	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—CD8A—celiac disease	0.000467	0.00108	CbGpPWpGaD
Carvedilol—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.000459	0.00106	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—MYO9B—celiac disease	0.000456	0.00106	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—MYO9B—celiac disease	0.000455	0.00105	CbGpPWpGaD
Carvedilol—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.000452	0.00105	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.000449	0.00104	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—ARHGAP31—celiac disease	0.000447	0.00103	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—CCR3—celiac disease	0.000446	0.00103	CbGpPWpGaD
Carvedilol—ADRB1—GPCR ligand binding—CCR4—celiac disease	0.000445	0.00103	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—ARHGAP31—celiac disease	0.000443	0.00102	CbGpPWpGaD
Carvedilol—VCAM1—Adaptive Immune System—CD4—celiac disease	0.000442	0.00102	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR ligand binding—CCR4—celiac disease	0.00044	0.00102	CbGpPWpGaD
Carvedilol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.000439	0.00102	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—ARHGAP31—celiac disease	0.000437	0.00101	CbGpPWpGaD
Carvedilol—ADRA2A—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.000436	0.00101	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—SH2B3—celiac disease	0.000435	0.00101	CbGpPWpGaD
Carvedilol—ADRB2—GPCR ligand binding—CCR4—celiac disease	0.000435	0.00101	CbGpPWpGaD
Carvedilol—ADRB3—GPCR downstream signaling—CCR4—celiac disease	0.000423	0.000979	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR ligand binding—CCR3—celiac disease	0.000415	0.00096	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—ARHGAP31—celiac disease	0.000413	0.000957	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR ligand binding—CCR4—celiac disease	0.000411	0.000952	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—ARHGAP31—celiac disease	0.000407	0.000942	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR ligand binding—CCR4—celiac disease	0.000405	0.000937	CbGpPWpGaD
Carvedilol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.000402	0.000929	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—TAGAP—celiac disease	0.000395	0.000915	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—TAGAP—celiac disease	0.000394	0.000913	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—PLEK—celiac disease	0.000394	0.000912	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—CCR4—celiac disease	0.000384	0.000889	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—HLA-DRB1—celiac disease	0.00038	0.00088	CbGpPWpGaD
Carvedilol—ABCB1—Allograft Rejection—HLA-DRB1—celiac disease	0.000379	0.000876	CbGpPWpGaD
Carvedilol—ADRB1—GPCR ligand binding—CCR3—celiac disease	0.000378	0.000875	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—LCT—celiac disease	0.000375	0.000867	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR ligand binding—CCR3—celiac disease	0.000375	0.000867	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—LCT—celiac disease	0.000374	0.000865	CbGpPWpGaD
Carvedilol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.000373	0.000864	CbGpPWpGaD
Carvedilol—ADRB2—GPCR ligand binding—CCR3—celiac disease	0.00037	0.000856	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—ARHGAP31—celiac disease	0.000361	0.000836	CbGpPWpGaD
Carvedilol—ADRB3—GPCR downstream signaling—CCR3—celiac disease	0.00036	0.000833	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR ligand binding—CCR4—celiac disease	0.00036	0.000832	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—RGS1—celiac disease	0.000357	0.000826	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—CD80—celiac disease	0.000351	0.000813	CbGpPWpGaD
Carvedilol—ABCB1—Allograft Rejection—CD80—celiac disease	0.00035	0.00081	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR ligand binding—CCR3—celiac disease	0.00035	0.00081	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR ligand binding—CCR3—celiac disease	0.000344	0.000797	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—ARHGAP31—celiac disease	0.000336	0.000777	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR ligand binding—CCR4—celiac disease	0.000334	0.000773	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—CCR3—celiac disease	0.000327	0.000756	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—SH2B3—celiac disease	0.000326	0.000755	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—RGS1—celiac disease	0.000325	0.000752	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—RGS1—celiac disease	0.000324	0.00075	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—RGS1—celiac disease	0.000322	0.000745	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—RGS1—celiac disease	0.000318	0.000736	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR ligand binding—CCR3—celiac disease	0.000306	0.000708	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—SH2B3—celiac disease	0.000305	0.000705	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—LCT—celiac disease	0.000304	0.000704	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—RGS1—celiac disease	0.000301	0.000696	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—MYO9B—celiac disease	0.000297	0.000687	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—RGS1—celiac disease	0.000296	0.000685	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—RGS1—celiac disease	0.000295	0.000683	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—RGS1—celiac disease	0.000294	0.00068	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—RGS1—celiac disease	0.000293	0.000678	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—RGS1—celiac disease	0.000292	0.000677	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—RGS1—celiac disease	0.000289	0.000668	CbGpPWpGaD
Carvedilol—HIF1A—Disease—CD80—celiac disease	0.000287	0.000665	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR ligand binding—CCR3—celiac disease	0.000284	0.000658	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—LCT—celiac disease	0.000279	0.000647	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—CCR4—celiac disease	0.000276	0.000638	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—RGS1—celiac disease	0.000273	0.000632	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—MYO9B—celiac disease	0.000271	0.000626	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—RGS1—celiac disease	0.000269	0.000622	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—MYO9B—celiac disease	0.000268	0.000621	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—CD4—celiac disease	0.000268	0.00062	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—MYO9B—celiac disease	0.000265	0.000613	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—LCT—celiac disease	0.000263	0.00061	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—RGS1—celiac disease	0.000263	0.000609	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TAGAP—celiac disease	0.000258	0.000596	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—CCR4—celiac disease	0.000251	0.000581	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MYO9B—celiac disease	0.00025	0.00058	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—CCR4—celiac disease	0.00025	0.000579	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—CCR4—celiac disease	0.000249	0.000576	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—SH2B3—celiac disease	0.000248	0.000573	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MYO9B—celiac disease	0.000247	0.00057	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—CCR4—celiac disease	0.000246	0.000569	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—RGS1—celiac disease	0.000244	0.000566	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—RGS1—celiac disease	0.000239	0.000553	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TAGAP—celiac disease	0.000235	0.000543	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—CCR3—celiac disease	0.000234	0.000542	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—CCR4—celiac disease	0.000233	0.000538	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TAGAP—celiac disease	0.000232	0.000538	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TAGAP—celiac disease	0.00023	0.000531	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—CCR4—celiac disease	0.000229	0.00053	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—CCR4—celiac disease	0.000228	0.000528	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—CCR4—celiac disease	0.000227	0.000525	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—CCR4—celiac disease	0.000227	0.000524	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—CCR4—celiac disease	0.000226	0.000523	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—CCR4—celiac disease	0.000223	0.000516	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—RGS1—celiac disease	0.000222	0.000514	CbGpPWpGaD
Carvedilol—HIF1A—Disease—CD4—celiac disease	0.000219	0.000508	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MYO9B—celiac disease	0.000219	0.000507	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TAGAP—celiac disease	0.000217	0.000503	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TAGAP—celiac disease	0.000214	0.000495	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—CCR3—celiac disease	0.000214	0.000494	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—CCR3—celiac disease	0.000213	0.000493	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—CCR3—celiac disease	0.000212	0.00049	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—CCR4—celiac disease	0.000211	0.000489	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—LCT—celiac disease	0.00021	0.000487	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—CCR3—celiac disease	0.000209	0.000484	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—CCR4—celiac disease	0.000208	0.000481	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MYO9B—celiac disease	0.000203	0.000471	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—CCR4—celiac disease	0.000203	0.00047	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—CD80—celiac disease	0.000201	0.000466	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—LCT—celiac disease	0.000198	0.000459	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—CCR3—celiac disease	0.000198	0.000458	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—LCT—celiac disease	0.000197	0.000455	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—CCR3—celiac disease	0.000195	0.00045	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—CCR3—celiac disease	0.000194	0.000449	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—CCR3—celiac disease	0.000193	0.000447	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—CCR3—celiac disease	0.000193	0.000446	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—CCR3—celiac disease	0.000192	0.000445	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—RGS1—celiac disease	0.000191	0.000443	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TAGAP—celiac disease	0.00019	0.000439	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—CCR3—celiac disease	0.00019	0.000439	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—CCR4—celiac disease	0.000189	0.000437	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—SH2B3—celiac disease	0.000188	0.000435	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—SH2B3—celiac disease	0.000188	0.000434	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—CCR4—celiac disease	0.000185	0.000427	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—CCR3—celiac disease	0.00018	0.000415	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—CCR3—celiac disease	0.000177	0.000409	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TAGAP—celiac disease	0.000176	0.000408	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—RGS1—celiac disease	0.000174	0.000404	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—CCR3—celiac disease	0.000173	0.0004	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—RGS1—celiac disease	0.000173	0.0004	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—CCR4—celiac disease	0.000171	0.000397	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—RGS1—celiac disease	0.000171	0.000395	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—LCT—celiac disease	0.000168	0.000389	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—RGS1—celiac disease	0.000161	0.000374	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—CCR3—celiac disease	0.000161	0.000372	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—RGS1—celiac disease	0.000159	0.000368	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—CCR3—celiac disease	0.000157	0.000363	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CCR4—celiac disease	0.000148	0.000342	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—CCR3—celiac disease	0.000146	0.000337	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—RGS1—celiac disease	0.000141	0.000327	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CCR4—celiac disease	0.000135	0.000312	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CCR4—celiac disease	0.000134	0.000309	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CCR4—celiac disease	0.000132	0.000305	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—RGS1—celiac disease	0.000131	0.000303	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—LCT—celiac disease	0.00013	0.0003	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CCR3—celiac disease	0.000126	0.000291	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CCR4—celiac disease	0.000125	0.000289	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CCR4—celiac disease	0.000123	0.000284	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—SH2B3—celiac disease	0.000123	0.000284	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CCR3—celiac disease	0.000115	0.000265	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CCR3—celiac disease	0.000114	0.000263	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CCR3—celiac disease	0.000112	0.000259	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—SH2B3—celiac disease	0.000112	0.000258	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—SH2B3—celiac disease	0.000111	0.000256	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—SH2B3—celiac disease	0.000109	0.000253	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CCR4—celiac disease	0.000109	0.000252	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CCR3—celiac disease	0.000106	0.000245	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CCR3—celiac disease	0.000104	0.000242	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—SH2B3—celiac disease	0.000103	0.000239	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—SH2B3—celiac disease	0.000102	0.000235	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CCR4—celiac disease	0.000101	0.000234	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CCR3—celiac disease	9.27e-05	0.000215	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—SH2B3—celiac disease	9.03e-05	0.000209	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—CD80—celiac disease	8.7e-05	0.000201	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—CD80—celiac disease	8.68e-05	0.000201	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CCR3—celiac disease	8.61e-05	0.000199	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—SH2B3—celiac disease	8.39e-05	0.000194	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CD80—celiac disease	5.67e-05	0.000131	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CD80—celiac disease	5.16e-05	0.00012	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CD80—celiac disease	5.12e-05	0.000118	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CD80—celiac disease	5.05e-05	0.000117	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CD80—celiac disease	4.78e-05	0.000111	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CD80—celiac disease	4.7e-05	0.000109	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CD80—celiac disease	4.18e-05	9.67e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CD80—celiac disease	3.88e-05	8.98e-05	CbGpPWpGaD
